Senior Director, Clinical Science, Oncology Early Development (Hybrid)

MSD•Boston, MA
•$210,400 - $331,100•Hybrid

About The Position

The Senior Director, Clinical Science, Oncology Early Development provides strategic Clinical Science leadership for novel oncology assets from candidate transition through first-in-human development and clinical proof-of-concept. Reporting to the Executive Director, the role applies expertise in early-phase oncology, translational medicine, biomarker strategy, and first-in-human trial design to shape development plans, strengthen scientific rigor, and enable objective, data-driven decisions across the early oncology portfolio. The Senior Director integrates clinical, pharmacokinetic, pharmacodynamic, biomarker, safety, and external scientific evidence to inform indication strategy, dose escalation and optimization, cohort expansion, and proof-of-concept assessments. The role partners with Section Heads, Asset Leads, Early Program Development Team Leads, study teams, and cross-functional leaders on study design, data interpretation, issue resolution, and program decisions. It also advances consistent Clinical Science practices across the portfolio and may directly manage and develop multiple Clinical Scientists. The position collaborates with Clinical Operations, Regulatory Affairs, Biostatistics and Data Management, Drug Safety and Pharmacovigilance, Translational Medicine, Medical Affairs, and other functions. It contributes to governance discussions and senior leadership reviews. The role is based in Rahway, New Jersey, with a hybrid work arrangement and 10% travel.

Requirements

  • Advanced scientific or healthcare degree, such as a PhD or PharmD, or equivalent, with 8 or more years of pharmaceutical, clinical drug development, and/or medical field experience preferred; alternatively, a master’s degree, preferably in life sciences, with 12 or more years of such experience; or a bachelor’s degree, preferably in life sciences, with 15 or more years of such experience.
  • Significant experience in Clinical Development, Clinical Science, clinical drug development, or a related pharmaceutical or biotechnology function, including substantial responsibility in early-phase development.
  • Demonstrated leadership of first-in-human and early-phase oncology studies, including dose escalation, dose optimization, cohort expansion, and proof-of-concept planning.
  • Deep understanding of oncology disease biology, novel mechanisms and modalities, translational medicine, biomarker-driven development, PK/PD, and safety and tolerability assessment.
  • Strong understanding of clinical trial design, clinical development strategy, clinical data review, and interpretation of oncology data.
  • Experience contributing to protocols, regulatory submissions, safety reviews, health authority interactions, governance discussions, and cross-program planning.
  • Experience working effectively in cross-functional teams in a matrixed environment.
  • Ability to integrate information across studies and programs to support scientific and business decision-making.
  • Excellent communication, influence, and executive presentation skills.
  • Demonstrated people leadership experience, including management, coaching, and development of scientific staff.
  • Required skills listed: Clinical Development, Clinical Research, Clinical Sciences, Clinical Study Management, Clinical Trial Development, Clinical Trial Management, Clinical Trials Operations, Disease Research, Early Phase Clinical Trials, and Oncology.

Nice To Haves

  • Preferred skills listed: Cross-Functional Teamwork, Decision Making, and Leadership.

Responsibilities

  • Provide strategic Clinical Science leadership across multiple Oncology Early Development studies, programs, and assets.
  • Contribute Clinical Science input to development strategy from candidate transition through first-in-human evaluation and clinical proof-of-concept.
  • Partner with program and functional leaders to align Clinical Science activities with program and disease-area objectives.
  • Integrate disease biology, mechanism of action, translational evidence, competitive landscape, and emerging data to identify development opportunities, risks, and decision points.
  • Connect insights across studies and assets to inform portfolio decisions and future development.
  • Establish and advance consistent standards for early development planning, medical data review, dose-escalation meetings, data interpretation, and key deliverables.
  • Promote scientific consistency while accounting for asset-specific biology, modality, and development questions.
  • Improve decision quality, operational efficiency, documentation, and inspection readiness; maintain awareness of emerging science, methodologies, regulatory expectations, and external innovations.
  • Advocate for visual analytics, centralized data review, AI-enabled workflows, and other technologies that improve quality and efficiency.
  • Guide interpretation of clinical data across studies, cohorts, and assets and help frame clinical, scientific, and data-related issues for cross-functional and governance discussions.
  • Contribute scientific perspective to protocols, amendments, study design, endpoint selection, eligibility criteria, biomarker strategy, and development planning.
  • Serve as a Clinical Science subject matter expert for Oncology Early Development across study teams and partner functions.
  • Contribute expertise and scientific content to portfolio discussions, governance reviews, program reviews, and senior leadership communications; present cross-study insights and assessments as appropriate.
  • Translate portfolio priorities into Clinical Science strategies, capabilities, and resource plans.
  • Directly manage Directors, Principal Scientists, and Clinical Scientists as appropriate; set expectations and support their development through coaching, mentoring, feedback, and development opportunities.
  • Promote consistent role expectations and ways of working, and foster accountability, collaboration, continuous learning, and high performance.
  • Partner with functional teams and represent Clinical Science in planning, program discussions, and strategic decision-making forums.
  • Facilitate alignment across studies, programs, and functions and communicate clinical and scientific issues to stakeholders and leaders.
  • Ensure Clinical Science activities comply with applicable regulatory requirements, company policies, and procedures; support inspection readiness and appropriate documentation.
  • Identify opportunities to improve Clinical Science quality, consistency, and effectiveness and apply relevant scientific, clinical, and regulatory developments to disease-area strategy and practice.

Benefits

  • Medical, dental, vision healthcare, and other insurance benefits for employees and family
  • Retirement benefits, including 401(k)
  • Paid holidays
  • Vacation
  • Compassionate and sick days
  • Eligible for annual bonus and long-term incentive, if applicable
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service